Cargando…

The hydrophobic C‐terminal sequence of transthyretin affects its catalytic kinetics towards amidated neuropeptide Y

Transthyretin (TTR) is a transporter for thyroid hormone and retinol binding protein that has recently been reported to have proteolytic activity against certain substrates, including amidated neuropeptide Y (NPY). However, the proteolytic activity of TTR towards NPY is not fully understood. Here, w...

Descripción completa

Detalles Bibliográficos
Autores principales: Tangthavewattana, Sukanya, Leelawatwattana, Ladda, Prapunpoj, Porntip
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6443995/
https://www.ncbi.nlm.nih.gov/pubmed/30984535
http://dx.doi.org/10.1002/2211-5463.12604
Descripción
Sumario:Transthyretin (TTR) is a transporter for thyroid hormone and retinol binding protein that has recently been reported to have proteolytic activity against certain substrates, including amidated neuropeptide Y (NPY). However, the proteolytic activity of TTR towards NPY is not fully understood. Here, we used fluorescence‐based assays to determine the catalytic kinetics of human TTR towards human amidated NPY. The Michaelis constant (K (M)) and catalytic efficiency (k (cat)/K (M)) of TTR proteolysis were 15.88 ± 0.44 μm and 687 081 ± 35 692 m (−1)·s(−1), respectively. In addition, we demonstrated an effect of the C‐terminal sequence of TTR. When the C‐terminal sequence of TTR was made more hydrophobic, the K (M) and k (cat)/K (M) changed to 12.87 ± 0.22 μm and 983 755 ± 18 704 m (−1)·s(−1), respectively. Our results may be useful for the development of TTR as a therapeutic agent with low risk of the undesirable symptoms that develop from amidated NPY, and for further improvement of the k (cat)/K (M) of TTR.